Early bisphosphonate treatment in infants with severe osteogenesis imperfecta
- 31 August 2006
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 149 (2), 174-179
- https://doi.org/10.1016/j.jpeds.2006.03.013
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects of Intravenous Pamidronate Treatment in Infants With Osteogenesis Imperfecta: Clinical and Histomorphometric OutcomeJournal of Bone and Mineral Research, 2005
- Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis ImperfectaTransplantation, 2005
- Intravenous Neridronate in Children With Osteogenesis Imperfecta: A Randomized Controlled StudyJournal of Bone and Mineral Research, 2005
- Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfectaBone, 2004
- Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfectaBone, 2004
- Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate TherapyJournal of Bone and Mineral Research, 2003
- Intravenous Neridronate in Adults With Osteogenesis ImperfectaJournal of Bone and Mineral Research, 2003
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaThe New England Journal of Medicine, 1998
- Adverse Effects of BisphosphonatesDrug Safety, 1996
- Hypercalciuria in children severely affected with osteogenesis imperfectaThe Journal of Pediatrics, 1991